The Use of Prophylactic Antibiotics in Isolated Blowout Fractures
NCT01504568 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2012-11-09
Summary
The purpose of the research is to perform a quality assurance evaluation using randomized prospective analysis the rate of orbital cellulitis as a complication of nonsurgical orbital blowout fracture in patients treated versus not treated with prophylactic antibiotics.
The investigators goal is to show the use of prophylactic antibiotics in orbital blowout fractures does not significantly decrease the rate of orbital cellulitis and is thus not indicated.
Conditions
- Orbital Fractures
- Orbital Cellulitis
Interventions
- OTHER
-
Treatment
Adults: ≥40 kg:250mg every eight hours Children: \<40kg: 20mg/kg/day divided in three doses (up to 250mg) every eight hours Suspension form 250mg/ml
Sponsors & Collaborators
-
University of Arkansas
lead OTHER
Principal Investigators
-
Christopher Westfall, M.D. · University of Arkansas
-
Bradley Thuro, M.D. · University of Arkansas
-
John Pemberton, D.O. · University of Arkansas
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 5 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-01-31
- Primary Completion
- 2012-11-30
- Completion
- 2012-11-30
Countries
- United States
Study Locations
More Related Trials
-
Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides
NCT00001473 ·Status: COMPLETED
-
Early Discontinuation of Steroid Treatment in Negative FDG-PET/CT Patients With Idiopathic Retroperitoneal Fibrosis
NCT05428826 ·Status: RECRUITING ·Phase: PHASE4
-
PRediction of DIverse Glucocorticoids ToxIcity OUtcomeS
NCT04664465 ·Status: RECRUITING
-
The Clinical Efficacy of DFPP in Patients With AAGN
NCT02294344 ·Status: TERMINATED ·Phase: NA
-
Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study
NCT01717170 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Microbiological Diagnosis of Infectious Uveitis to Pathogenic Fastidious Germs
NCT02819206 ·Status: COMPLETED ·Phase: NA
-
Evaluate the Remission MAINtenance Using Extended Administration of Prednisone in Systemic Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis.
NCT03290456 ·Status: RECRUITING ·Phase: NA
-
Study of Subcutaneous Injection of Low-dose rhGM-CSF +/- WLL in PAP.
NCT01983657 ·Status: UNKNOWN ·Phase: PHASE2
-
MMF Versus CYC in the Induction Therapy of Pediatric Active Proliferative LN
NCT05495893 ·Status: UNKNOWN ·Phase: PHASE4
-
Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis
NCT00987389 ·Status: COMPLETED ·Phase: PHASE3
-
Incidence and Risk Factors for Infections in Patient Treated With Corticosteroids, Immunosuppressive Drugs or Biotherapy for Immunologic and Inflammatory Diseases
NCT02280902 ·Status: COMPLETED
-
The Longitudinal Evaluation of Autoimmune Pulmonary Alveolar Proteinosis
NCT03531996 ·Status: COMPLETED
-
Quality of Life in Patients With Auto-inflammatory Diseases
NCT03569644 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease
NCT00685373 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis
NCT02169219 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetically-driven Dosing of Mycophenolate Mofetil for the Treatment of Pediatric Proliferative Lupus Nephritis
NCT05101447 ·Status: WITHDRAWN ·Phase: PHASE2
-
CellCept in p-ANCA Vasculitis
NCT00405860 ·Status: COMPLETED ·Phase: PHASE1
-
Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides
NCT00430105 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Comparison of ANCA and Anti-GBM Auto-antibodies Removal Kinetics Between Plasma Exchanges and Immunoadsorption in Patients With ANCA-associated Vasculitis or Anti-GBM Disease
NCT03635385 ·Status: COMPLETED ·Phase: NA
-
Aetiology of TemporaL Arteritis Study
NCT02584517 ·Status: WITHDRAWN
-
A Prospective, Non-interventional, Observational Study of Presentation, Treatment Patterns and Outcomes in Atypical Hemolytic Uremic Syndrome Patients
NCT06099236 ·Status: ACTIVE_NOT_RECRUITING
-
THE EFFECT OF COLD APPLICATION ON THE DEVELOPMENT OF PHLEBITIS IN PATIENTS RECEIVING INTRAVENOUS AMIODARONE TREATMENT.
NCT05058053 ·Status: COMPLETED ·Phase: NA
-
Splenectomy as a Treatment for Patient With Relapsed Haemophagocytic Lymphohistiocytosis of Unknown Etiology
NCT02862054 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Obinutuzumab for Remission Induction in Patients With Relapsing PR3-ANCA Granulomatosis With Polyangiitis
NCT06940661 ·Status: RECRUITING ·Phase: PHASE2
-
Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA)
NCT00103792 ·Status: COMPLETED ·Phase: PHASE3